Search

Your search keyword '"Bruce M. Robinson"' showing total 19 results
Start Over Author "Bruce M. Robinson" Publisher oxford university press (oup)
19 results on '"Bruce M. Robinson"'

1. Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients

Author

Kosaku Nitta, Katarina Hedman, Roberto Pecoits-Filho, Angelo Karaboyas, Bruce M. Robinson, Carol Moreno Quinn, Glen James, and Patricia de Sequera

Subjects
medicine.medical_specialty, Hyperkalemia, medicine.medical_treatment, Population, 030232 urology & nephrology, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Internal medicine, Medicine, AcademicSubjects/MED00340, education, Dialysis, Transplantation, education.field_of_study, hemodialysis, business.industry, Proportional hazards model, potassium, Hazard ratio, nutritional and metabolic diseases, Original Articles, hyperkalemia, mortality, Confidence interval, Nephrology, Hemodialysis, medicine.symptom, business, hospitalization
Abstract

Background Hyperkalemia is common among hemodialysis (HD) patients and has been associated with adverse clinical outcomes. Previous studies considered a single serum potassium (K) measurement or time-averaged values, but serum K excursions out of the target range may be more reflective of true hyperkalemia events. We assessed whether hyperkalemia excursions lead to an elevated risk of adverse clinical outcomes. Methods Using data from 21 countries in Phases 4–6 (2009–18) of the Dialysis Outcomes and Practice Patterns Study (DOPPS), we investigated the associations between peak serum K level, measured monthly predialysis, over a 4-month period (‘peak K’) and clinical outcomes over the subsequent 4 months using Cox regression, adjusted for potential confounders. Results The analysis included 62 070 patients contributing a median of 3 (interquartile range 2–6) 4-month periods. The prevalence of hyperkalemia based on peak K was 58% for >5.0, 30% for >5.5 and 12% for >6.0 mEq/L. The all-cause mortality hazard ratio for peak K (reference ≤5.0 mEq/L) was 1.15 [95% confidence interval (CI) 1.09, 1.21] for 5.1–5.5 mEq/L, 1.19 (1.12, 1.26) for 5.6–6.0 mEq/L and 1.33 (1.23, 1.43) for >6.0 mEq/L. Results were qualitatively consistent when analyzing hospitalizations and a cardiovascular composite outcome. Conclusions Among HD patients, we identified a lower K threshold (peak K 5.1–5.5 mEq/L) than previously reported for increased risk of hospitalization and mortality, with the implication that a greater proportion (>50%) of the HD population may be at risk. A reassessment of hyperkalemia severity ranges is needed, as well as an exploration of new strategies for effective management of chronic hyperkalemia.

Published
2020
Full Text
View/download PDF

2. Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS

Author

Sebastian Walpen, Roberto Pecoits-Filho, Pieter Evenepoel, Marisa Pegoraro, Brian Bieber, Angelo Karaboyas, Marcelo Barreto Lopes, Ronald L. Pisoni, Bruce M. Robinson, Anders Christensson, and Masafumi Fukagawa

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, chemistry.chemical_element, survival, cardiovascular disease, Renal Dialysis, Internal medicine, medicine, Humans, Prospective Studies, phosphorus, AcademicSubjects/MED00340, Prospective cohort study, Dialysis, Aged, Proportional Hazards Models, Transplantation, hemodialysis, Proportional hazards model, business.industry, Phosphorus, Hazard ratio, Area under the curve, Original Articles, Middle Aged, Prognosis, Confidence interval, Survival Rate, chemistry, Cardiovascular Diseases, Nephrology, Area Under Curve, Cardiology, Female, Hemodialysis, business, mineral bone disease
Abstract

Background Serial assessment of phosphorus is currently recommended by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, but its additional value versus a single measurement is uncertain. Methods We studied data from 17 414 HD patients in the Dialysis Outcomes and Practice Patterns Study, a prospective cohort study, and calculated the area under the curve (AUC) by multiplying the time spent with serum phosphorus >4.5 mg/dL over a 6-month run-in period by the extent to which this threshold was exceeded. We estimated the association between the monthly average AUC and cardiovascular (CV) mortality using Cox regression. We formally assessed whether AUC was a better predictor of CV mortality than other measures of phosphorus control according to the Akaike information criterion. Results Compared with the reference group of AUC = 0, the adjusted hazard ratio (HR) of CV mortality was 1.12 [95% confidence interval (CI) 0.90–1.40] for AUC > 0–0.5, 1.26 (95% CI 0.99–1.62) for AUC > 0.5–1, 1.44 (95% CI 1.11–1.86) for AUC > 1–2 and 2.03 (95% CI 1.53–2.69) for AUC > 2. The AUC was predictive of CV mortality within strata of the most recent phosphorus level and had a better model fit than other serial measures of phosphorus control (mean phosphorus, months out of target). Conclusions We conclude that worse phosphorus control over a 6-month period was strongly associated with CV mortality. The more phosphorus values do not exceed 4.5 mg/dL the better is survival. Phosphorus AUC is a better predictor of CV death than the single most recent phosphorus level, supporting with real-world data KDIGO’s recommendation of serial assessment of phosphorus to guide clinical decisions.

Published
2020
Full Text
View/download PDF

3. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study

Author

Charlotte Tu, Gerhard Lonnemann, Danilo Fliser, Johannes Duttlinger, Jarcy Zee, Ronald L. Pisoni, Bruce M. Robinson, Bénédicte Stengel, Eric W. Young, Roberto Pecoits-Filho, and Helmut Reichel

Subjects
Male, Nephrology, medicine.medical_specialty, CKD progression, Renal function, urologic and male genital diseases, Risk Factors, Germany, Internal medicine, Diabetes mellitus, medicine, Humans, Prospective Studies, Practice Patterns, Physicians', Renal Insufficiency, Chronic, Aged, Aged, 80 and over, Transplantation, Proportional hazards model, business.industry, Incidence, Original Articles, Middle Aged, Prognosis, medicine.disease, mortality, Comorbidity, Survival Rate, Cohort, Disease Progression, Albuminuria, Female, medicine.symptom, business, chronic kidney disease, Glomerular Filtration Rate, Kidney disease
Abstract

Background Chronic kidney disease (CKD) progression among German patients in a representative setting has not been described previously. The Verband Deutsche Nierenzentren and Chronic Kidney Disease Outcomes and Practice Patterns Study established a longitudinal observational cohort among German CKD patients to research variations in patient care and outcomes in real-world nephrology practices. Methods A cohort of CKD Stages 3 (25%) and 4 (75%) patients was established from German nephrologist-run CKD clinics in 2013–16. Linear models were used to determine the estimated glomerular filtration rate (eGFR) slope during follow-up and Cox models were used to assess outcomes of end-stage kidney disease (ESKD) and death. Results A total of 1834 patients (median age 75 years, 58% male, 42% diabetics, median baseline eGFR 25 mL/min/1.73 m2) were followed for a median of 29 months. More than 50% had slow or no decline and 17% declined ≥5 mL/min/1.73 m2/year. After 4.5 years, the incidence of ESKD was 8% and of deaths without ESKD 16% among patients with eGFR ≥30 mL/min/1.73 m2 and 37% and 19% for eGFR Conclusions Routine nephrology care of patients in Germany comprises mostly elderly patients, many with slow CKD progression. Identification of risk factors for CKD progression and mortality may help guide resources by closer follow-up of high-risk patients.

Published
2020
Full Text
View/download PDF

4. Dialysate Sodium Prescription and Blood Pressure in Hemodialysis Patients

Author

Ananda Sen, Bruce M. Robinson, Ronald L. Pisoni, Manfred Hecking, Friedrich K. Port, Masaaki Inaba, Walter H. Hörl, Rajiv Saran, Jürgen Bommer, Gere Sunder-Plassmann, Angelo Karaboyas, and Hugh C. Rayner

Subjects
Male, Dialysate sodium, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Sodium, chemistry.chemical_element, Blood Pressure, Renal Dialysis, Risk Factors, Dialysis Solutions, Internal medicine, Prevalence, Internal Medicine, medicine, Humans, Prospective Studies, Practice Patterns, Physicians', Medical prescription, Antihypertensive Agents, Dialysis, Practice patterns, business.industry, Surgery, Prescriptions, Treatment Outcome, Blood pressure, chemistry, Hypertension, Multivariate Analysis, Linear Models, Cardiology, Female, Kidney Diseases, Hemodialysis, Intradialytic hypotension, business
Abstract

background Diffusive sodium removal has been recommended to control hypertension in hemodialysis patients. Recent evidence on hospitalizations and mortality, however, challenged the benefit of lower dialysate sodium prescriptions and ignited a debate in the dialysis community. We therefore studied the relationship between dialysate sodium and blood pressure over the longer term. methods We used multiply adjusted linear mixed models to estimate the association between dialysate sodium and predialysis systolic blood pressure (SBP) as well as change in SBP (delta SBP; postdialysis minus predialysis) in 23,962 patients from the international Dialysis Outcomes and Practice Patterns Study. results We found that 43% of hemodialysis facilities had variable (individualized) dialysate sodium prescriptions (125–155 mEq/L), whereas 57% had uniform dialysate sodium prescriptions (135–145 mEq/L) for ≥90% patients. Between-group comparisons of these 2 facility types suggested that dialysate sodium, when variably prescribed, might have been used to modify predialysis SBP (Pinteraction = 0.01) and perhaps delta SBP levels (Pinteraction = 0.08). Within facilities not prone to indication bias, because dialysate sodium was not variable, higher uniform dialysate sodium (per 2 mEq/L) was associated with slightly higher SBP (+0.9 mm Hg, 95% confidenc e interval (CI) = 0.1–1.6 among all patients; +1.7 mm Hg, 95% CI = 0.1–3.2 among patients not treated with blood pressure medication) and no increase in delta SBP. conclusions Patients assigned to hemodialysis facilities with uniformly higher dialysate sodium do not have markedly higher predialysis SBP, providing rather limited support for lowering dialysate sodium to control hypertension, particularly in view of hospitalization and mortality risks associated with lower dialysate sodium.

Published
2014
Full Text
View/download PDF

5. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study

Author

Nan Chen, Brian Bieber, Bruce M. Robinson, Li Zuo, Mia Wang, Yucheng Yan, Fan Fan Hou, Mei Wang, Jiaqi Qian, Shuchi Anand, Sylvia P. B. Ramirez, and Ronald L. Pisoni

Subjects
Transplantation, medicine.medical_specialty, Practice patterns, Cross-sectional study, business.industry, medicine.medical_treatment, medicine.disease, Comorbidity, Quality of life, Nephrology, medicine, Hemodialysis, Renal replacement therapy, China, Intensive care medicine, business, Dialysis
Abstract

Background Renal replacement therapy is rapidly expanding in China, and two-times weekly dialysis is common, but detailed data on practice patterns are currently limited. Using cross-sectional data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we describe the hemodialysis practice in China compared with other DOPPS countries, examining demographic, social and clinical characteristics of patients on two-times weekly dialysis.

Published
2013
Full Text
View/download PDF

6. Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes

Author

Juergen Bommer, Rajiv Saran, Marcia L. Keen, Jyothi Thumma, Stacey J. Elder, Ronald L. Pisoni, Sylvia P. B. Ramirez, Michel Jadoul, Rachel B. Fissell, Francesca Tentori, Shunichi Fukuhara, and Bruce M. Robinson

Subjects
Male, medicine.medical_specialty, Cross-sectional study, Population, Physical exercise, Quality of life, Renal Dialysis, Outcome Assessment, Health Care, Humans, Medicine, Practice Patterns, Physicians', education, Aged, Transplantation, education.field_of_study, business.industry, Hazard ratio, International Agencies, Odds ratio, Middle Aged, Confidence interval, Exercise Therapy, Cross-Sectional Studies, Treatment Outcome, Nephrology, Quality of Life, Physical therapy, Kidney Failure, Chronic, Female, business, Psychosocial, Follow-Up Studies
Abstract

Background. Levels of physical exercise among haemodialysis patients are low. Increased physical activity in this population has been associated with improved health-related quality of life (HRQoL) and survival. However, results of previous studies may not be applicable to the haemodialysis population as a whole. The present study provides the first description of international patterns of exercise frequency and its association with exercise programmes and clinical outcomes among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Methods. Data from a cross section of 20 920 DOPPS participants in 12 countries between 1996 and 2004 were analysed. Regular exercise was defined as exercise frequency equal to or more than once/week based on patient self-report. Linear mixed models and logistic regression assessed associations of exercise frequency with HRQoL and other psychosocial variables. Mortality risk was calculated in Cox proportional hazard models using patient-level (patient self-reported exercise frequency) and facility-level (the dialysis facility percentage of regular exercisers) predictors. Results. Regular exercise frequency varied widely across countries and across dialysis facilities within a country. Overall, 47.4% of participants were categorized as regular exercisers. The odds of regular exercise was 38% higher for patients from facilities offering exercise programmes (adjusted odds ratio = 1.38 [95% confidence interval: 1.03-1.84]; P = 0.03). Regular exercisers had higher HRQoL, physical functioning and sleep quality scores; reported fewer limitations in physical activities; and were less bothered by bodily pain or lack of appetite (P 0.0001 for all). Regular exercise was also correlated with more positive patient affect and fewer depressive symptoms (P 0.0001). In models extensively adjusted for demographics, comorbidities and socio-economic indicators, mortality risk was lower among regular exercisers (hazard ratio = 0.73 [0.69-0.78]; P < 0.0001) and at facilities with more regular exercisers (0.92 [0.89-0.94]; P < 0.0001 per 10% more regular exercisers). Conclusions. Results from an international study of haemodialysis patients indicate that regular exercise is associated with better outcomes in this population and that patients at facilities offering exercise programmes have higher odds of exercising. Dialysis facility efforts to increase patient physical activity may be beneficial.

Published
2010
Full Text
View/download PDF

7. Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS

Author

Jennifer L. Bragg-Gresham, Eric W. Young, Akira Saito, Friedrich K. Port, Antonio Alberto Lopes, Bruce M. Robinson, Sylvia P. B. Ramirez, Takashi Akiba, Vittorio E. Andreucci, Nancy A. Mason, and Stefan H. Jacobson

Subjects
Adult, Male, medicine.medical_specialty, Angiotensin receptor, Time Factors, medicine.drug_class, medicine.medical_treatment, Patient characteristics, Renal Dialysis, Risk Factors, Internal medicine, medicine, Humans, Prospective Studies, Practice Patterns, Physicians', Medical prescription, Beta blocker, Antihypertensive Agents, Aged, Transplantation, Proportional hazards model, business.industry, Dihydropyridine, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Cardiovascular Diseases, Nephrology, Kidney Failure, Chronic, Female, Hemodialysis, business, medicine.drug, Kidney disease
Abstract

Background. Haemodialysis patients were studied in 12 countries to identify practice patterns of prescription of antihypertensive agents (AHA) associated with survival. Methods. The sample included 28 513 patients enrolled in DOPPS I and II. The classes of AHA studied were beta blocker (BB), angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), peripheral blocker, central antagonist, vasodilator, long-acting dihydropyridine calcium channel blocker (CCB), short-acting dihydropyridine CCB and non-dihydropyridine CCB. To reduce bias due to unmeasured confounders, the associations with mortality were assessed by separate Cox models based on patient-level prescription and facility prescription practice. Results. An increase in prescription of ARBs (9.5%) and BBs (9.1%) was observed from DOPPS I to II. Prescription of AHA classes varied significantly by country, ranging for BBs from 9.7% in Japan to 52.7% in Sweden and for ARBs from 5.5% in Italy to 21.3% in Japan in DOPPS II. Facilities that treated 10% more patients with ARBs had, on average, 7% lower all-cause mortality, independent of patient characteristics and the prescription patterns of other antihypertensive medications (P = 0.05). Significant and independent associations with reduction in cardiovascular mortality were observed for ARBs (RR = 0.79; P = 0.005) and BBs (RR = 0.87, P = 0.004) in analyses of patient-level prescriptions. These associations in the facility-level model followed the same direction. Conclusions. DOPPS data show large variations across countries in AHA prescription for haemodialysis patients. The data suggest an association between ARB use and reduction in all-cause mortality, as well as with the use of BBs and reduction in cardiovascular mortality among haemodialysis patients.

Published
2009
Full Text
View/download PDF

8. SP564COPMARISON OF IMMUNOSUPPRESSIVE MEDICATION PRESCRIBED AMONG HEMODIALYSIS PATIENTS WITH FAILED KIDNEY TRANSPLANTS IN EUROPE, AUSTRALIA & NEW ZEALAND, AND NORTH AMERICA, FROM THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY

Author

Hal Morgenstern, Richard Fluck, Bruce M. Robinson, Maria Larkina, Alan B. Leichtman, Francesca Tentori, Jarcy Zee, and Joan Fort

Subjects
Transplantation, medicine.medical_specialty, Kidney, medicine.anatomical_structure, Nephrology, Practice patterns, business.industry, medicine.medical_treatment, medicine, Hemodialysis, Intensive care medicine, business, Dialysis
Published
2016
Full Text
View/download PDF

9. SP575PREVALENCE AND AWARENESS AND TREATMENT OF URAEMIC PRURITUS IN PEOPLE ON AEMODIALYSIS: INTERNATIONAL COMPARISONS FROM THE DOPPS

Author

Matthew P M Graham-Brown, Mia Wang, Ronald L. Pisoni, Bruce M. Robinson, Francesca Tentori, Sabine N. van der Veer, Hugh C. Rayner, and Brian Bieber

Subjects
Transplantation, medicine.medical_specialty, Nephrology, business.industry, Family medicine, International comparisons, Physical therapy, Medicine, business
Published
2016
Full Text
View/download PDF

10. SO037ANEMIA PREVALENCE AND TREATMENT AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3-5: DATA FROM THE CHRONIC KIDNEY DISEASE OUTCOMES AND PRACTICE PATTERNS STUDY (CKDOPPS)

Author

Roberto Pecoits-Filho, Friedrich K. Port, Helmut Reichel, Michelle M.Y. Wong, Christian Combe, Lindsay Zepel, Ziad A. Massy, Bruce M. Robinson, Antonio Alberto Lopes, Charlotte Tu, and Ronald L. Pisoni

Subjects
0301 basic medicine, Transplantation, medicine.medical_specialty, Practice patterns, business.industry, 030232 urology & nephrology, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Nephrology, Internal medicine, Medicine, Stage (cooking), business, Kidney disease
Published
2016
Full Text
View/download PDF

11. SP388UNIQUE HEMOGLOBIN A1C LEVEL DISTRIBUTION AND ITS RELATIONSHIP WITH MORTALITY SEEN FOR DIABETIC JAPANESE HEMODIALYSIS PATIENTS: RESULTS FROM THE JAPANESE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY

Author

Maria Larkina, Kenmei Takaichi, Yoshifumi Ubara, Brian Bieber, Shunichi Fukuhara, Angelo Karaboyas, Tadao Akizawa, Bruce M. Robinson, Ronald L. Pisoni, Takashi Akiba, Junichi Hoshino, and Akira Saito

Subjects
Transplantation, medicine.medical_specialty, Nephrology, Practice patterns, business.industry, medicine.medical_treatment, medicine, Distribution (pharmacology), Hemodialysis, Hemoglobin, Intensive care medicine, business, Dialysis
Published
2016
Full Text
View/download PDF

12. FP647FACILITY BLOOD PRESSURE TARGETS AND RISK OF LOW OBSERVED BLOOD PRESSURE LEVELS IN THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)

Author

Friedrich K. Port, Michelle M.Y. Wong, Jarcy Zee, Werner Kleophas, Tadao Akizawa, Ronald L. Pisoni, Patricia de Sequera, Francesca Tentori, and Bruce M. Robinson

Subjects
Transplantation, medicine.medical_specialty, Blood pressure, Nephrology, Practice patterns, business.industry, medicine.medical_treatment, medicine, Hemodialysis, business, Intensive care medicine, Dialysis
Published
2015
Full Text
View/download PDF

13. SP582ASSOCIATIONS OF EMPLOYMENT STATUS AND EDUCATIONAL LEVELS WITH MORTALITYAND HOSPITALIZATION IN THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY IN JAPAN

Author

Yasuo Imanishi, Shingo Fukuma, Masaaki Inaba, Tadao Akizawa, Ronald L. Pisoni, Bruce M. Robinson, Takashi Akiba, Shunichi Fukuhara, Takanobu Nomura, and Angelo Karaboyas

Subjects
Transplantation, medicine.medical_specialty, Nephrology, Practice patterns, business.industry, Family medicine, medicine, Intensive care medicine, Dialysis (biochemistry), business
Published
2016
Full Text
View/download PDF

14. SP295PRURITIS IN CHRONIC KIDNEY DISEASE PATIENTS: EARLY RESULTS FROM CKDOPPS

Author

Ronald L. Pisoni, Mia Wang, Brian Bieber, Bruce M. Robinson, Antonio Alberto Lopes, Bénédicte Stengel, Nidhi Sukul, Elodie Speyer, Yun Li, Ckd Rein investigators, and Laura H. Mariani

Subjects
Nephrology, Transplantation, medicine.medical_specialty, business.industry, 030232 urology & nephrology, 030204 cardiovascular system & hematology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Early results, Internal medicine, medicine, business, Kidney disease
Published
2016
Full Text
View/download PDF

15. SP297PATIENTS’ PERSPECTIVES ON EDUCATION RECEIVED ABOUTKIDNEY DISEASE AND RENAL REPLACEMENT THERAPY: RESULTS FROM THE CHRONIC KIDNEY DISEASE OUTCOMES AND PRACTICE PATTERNS STUDY (CKDOPPS)

Author

Elodie Speyer, Ronald L. Pisoni, Laura H. Mariani, Bruce M. Robinson, Charlotte Tu, Serge Briançon, Bénédicte Stengel, Antonio Alberto Lopes, Nidhi Sukul, and Francesca Tentori

Subjects
Nephrology, Transplantation, medicine.medical_specialty, Practice patterns, business.industry, medicine.medical_treatment, Disease, medicine.disease, Internal medicine, medicine, Renal replacement therapy, business, Intensive care medicine, Kidney disease
Published
2016
Full Text
View/download PDF

17. Cardiovascular complications in CKD 5D (1)

Author

P. De Sequera, Michal Mysliwiec, David C. Mendelssohn, Ferdinand H. Bahlmann, Jolanta Malyszko, Vera Sperber, Andrzej Krasniak, S. Liakos, Socorro Braga, Jorge Rico, Sandip Kumar Bhattacharya, Oktay Karatan, Carlo Ratti, Geoffrey Block, Luís Belo, Juan Jesus Carrero, Sung Jin Moon, E. Ferramosca, Kyriaki Kollia, Joon Seok Oh, Panagiotis Korantzopoulos, Kenan Ates, Satoko Okamoto, Jorge Henao, Amalia Fernandez-Vazquez, John Kyriazis, Kiyoko Yamamoto, Giovanni Tripepi, Joaquin Rodelo, Joon Ho Song, Aris Bechlioulis, Mieczysław Pasowicz, Piotr Kuczera, Jwa-Kyung Kim, Gjulsen Selim, Naoki Kimata, Natalia Carrillo-Lopez, Sung Min Kim, Alice Santos-Silva, Gokhan Nergizoglu, Fatih Kircelli, Janusz Wyroslak, Yasuharu Tohara, Antonio Bellasi, Bo Feldt-Rasmussen, John Rogus, Chandra Sekhar Panja, Ozkan Gungor, Mehmet Ozkahya, Chung Hee Baek, Minako Tanikake, Haruna Tasaki, Erhan Tatar, Sim Kutlay, Miwa Ishihara, Afroditi Vlachopanou, Valerios Foulidis, Keiko Yasuda, Alvaro Garcia, Eduardo Lacson, Hye Rim An, St. Kapoulas, Valeria Cernaro, Sara Panizo, Neval Duman, Won Hong Kim, Marcin Adamczak, B. Gillespie, D. Mendonça, Nathan W. Levin, Ercan Ok, Eirini Pagiati, Petros Nikolopoulos, Olga V. Fedorova, Manfred Hecking, Kyung Min Kim, J. Thumma, Stephan Thijssen, Valentina Donato, C. Combe, Soon Bae Kim, Len A. Usvyat, Antonio Lacquaniti, Yong Hun Sin, Ellen Becker, Shioko Okada, Korosh Shareain, Jawed Fareed, Stephen Zewinger, Koichi Sasaki, Rajiv Saran, Gonzalo Mejía, Pavlina Dzekova, Debra Hoppensteadt, Maria do Sameiro-Faria, Sule Sengul, Belinda Spoto, Alessandra Testa, Vinod Bansal, Anetta Undas, Aleksandar Sikole, Marek Kolarz, Moon-Jae Kim, Adolfo Romeo, Jakob T. Bay, Paul Balter, Jung Eun Lee, Ewa Koc-Zurawska, Nozomu Kamiura, V. Miranda, B. Robinson, Piotr Podolec, Peter Kotanko, M. Nikodimopoulou, Joong Kyung Kim, Carmine Zoccali, Maria Cardona, Galina Severova, Shigeru Otsubo, Kenan Keven, Panagiota Papanikolaou, Elísio Costa, Angelo Karaboyas, Joon Kweon, Hyeong Cheon Pakr, Kosaku Nitta, Eleni Kardouli, Irene Katsipi, Sung Kyu Ha, Andrzej Wiecek, Katarzyna Klejna, Inge Arroyave, Ulrich Laufs, Terumasa Hayashi, Saso Gelev, Ananda Sen, Seoung Woo Lee, Paolo Raggi, Beata Naumnik, Claudia Noll, Danilo Fliser, Grzegorz Chmiel, Lorenzo Malatino, Chariklia Gouva, Apostolos Tatsiopoulos, Hiroyasu Yamamoto, Grzegorz Piecha, Hideki Kawanishi, Svetlana Pavleska, Jesper Melchior Hansen, Saubhik Sural, Ko-Lin Kuo, Takashi Akiba, Len Usvyat, Masaki Hatanaka, Alexei Y. Bagrov, Liljana Tozija, Kallirroi Kalantzi, Lada Trajcevska, Maria Gennadiou, Peter Garred, Sehsuvar Erturk, Kiyoshi Matsuoka, Nikola Stojcev, Evangelos Asmanis, Kenji Arizono, Makoto Sakai, Eiji Yamauchi, Elisabeth R. Mathiesen, Petronila Rocha-Pereira, Władysław Sułowicz, Gulay Asci, Meltem Sezis Demirci, A. Quintanilha, Jochen G. Raimann, Bulent Erbay, Martyna Kowalczyk-Michalek, Szu-Chun Hung, Bruce M. Robinson, Christos Doulgerakis, Mads Hornum, Manuel Naves-Diaz, A. Borges, Maciej Drozdz, Olivera Stojceva-Taneva, Peter Clausen, Maria Cristina Sanguedolce, F. Reis, Michel Jadoul, Wieslawa Tracz, Sara Barrio-Vazquez, Francesca Mallamaci, Michele Buemi, Sarah Triem, Henrique Nascimento, Ana Rodriguez-Rebollar, Mario Arbelaez, Evangelos Litinas, Yoshio Matsushita, Giuseppina Lorenzano, Huseyin Toz, Der-Cherng Tarng, L. Amado, Jorge B. Cannata-Andía, and Akira Fujimori

Subjects
Transplantation, medicine.medical_specialty, Nephrology, business.industry, medicine, Intensive care medicine, business
Published
2011
Full Text
View/download PDF

18. Bone disease in CKD 5D

Author

Adrian Zugravu, Emre Tutal, Ananda Sen, Clorinda Derosa, Vincent Pichette, Jesus Montenegro, Zeynep Bal, Yukie Kitajima, Annie-Claire Nadeau-Fredette, A. Junqué, Miroslaw Kroczak, Nathan W. Levin, Monika Mlot-Michalska, Yoshihiro Onishi, Angel L.M. de Francisco, Manuel Casado, Young Ki Son, Anna Lucia Di Turo, Hana Novotná, Zeki Tonbul, Antonio Bordils, Oana Schiller, Anne-Marie Dupuis, Andrea Bruno, Francesca Tentori, Cristóbal Vicent, Marjan Mohanna, Won Suk An, Władysław Sułowicz, Beatrix Büschges-Seraphin, Ilaria Petrucci, M. Ramirez de Arellano, Domenico Chimienti, Violeta Roman, Takashi Akiba, Cristina Marelli, Tadao Akizawa, Mario Meola, Pasquale Libutti, Soledad Crucelegui, Shunichi Fukuhara, Senji Okuno, Pablo Bevione, Laura Rosales, Luigi Vernaglione, Hae Rahn Bae, Naoki Tsuboniwa, Angelo Karaboyas, Cesar E. Bogado, Seong Eun Kim, Takeshi Hasegawa, Antonio Crespo, Laure Patrier, Denis Ouimet, Nurhan Ozdemir Acar, José Lacueva, Olynka Vega, Alicja E. Grzegorzewska, Masaaki Inaba, Elisa E. Del Valle, Robert Bell, Marcelo Puddu, Crina Raletchi, Elisa Del Valle, Pei-Chun Chiang, Ing-Ching Jong, Marek Kuzniewski, Bruce M. Robinson, Marina Bravo, Friedrich Schulze, Pedro Ponce, Tom Depner, Zsofia Ivacson, Lofti Chalabi, Josep Mora, Hitoshi Nakayama, F. Nurhan Ozdemir Acar, František Švára, Juergen Bommer, Sara Samoni, Yongsoon Park, Dorota Pawlica, Kiyoshi Kurokawa, Rosamund Wilson, A. Sanchez Ramos, Harumi Ogawa, Carlo Lomonte, Eva Sedlácková, Ki Hyun Kim, Carlo Basile, Masashi Suzuki, Alexandre Granger Vallée, V. Duarte, M. Pou, M. Fulquet, Adrian Covic, J. Brian Copley, Myriam Lessard, Michel Vallée, Taeko Takahashi, Alicia Marini, Shigeichi Shoji, Hisaki Shimada, Peter Kotanko, Shigeru Miyazaki, Nicola Losurdo, Joy Mallari, Len A. Usvyat, Mª Teresa González, Ryo Kido, V. Esteve, Lynne Poole, Siren Sezer, Adamasco Cupisti, Noriko Saito, María B. Zanchetta, Yalcin Solak, Bogdan Solnica, Cristina Anghel, Francesco Casucci, Eiji Ishimura, Annalisa Teutonico, Hans-Juergen Arens, Guillermo Rosa Diez, Shinji Sakai, Rosario Moreno, Takuhiro Yamaguchi, Vladimír Polakovic, Jean-Philippe Lafrance, Hiroshi Kikuchi, Houshang Sanadgol, Jutta Passlick-Deetjen, Armando Luis Negri, Luis Sintado, Huseyin Atalay, Emilio González, Sebnem Karakan, Lisa Giovannini, Marisa Nobaru, Suzana Berca, K. Salas, Yuzuru Sato, Mahé Fernández, Mª Luisa Muñiz, Roberto Barone, Ligia Petrescu, Masafumi Fukagawa, Marcin Krzanowski, Carmen Anton, Mehtap Erkmen Uyar, Vicente Torregrosa, Jose R. Zanchetta, Peter Kaufmann, Jaime Ryba, Sheila Cayabyab, Friedrich K. Port, Bernard Canaud, Maurizio Antonelli, Katarzyna Janda, Carmen Santamaría, Danuta Fedak, Jorge Cannata, Tomoyuki Yamakawa, Beata Kusnierz-Cabala, Mª Dolores Arenas, Bogdan Stanescu, Carmen Barbulescu, Jean-Paul Cristol, Manfred Hecking, Mitsuru Ichii, Michael Smyth, Stephan Thijssen, Elisa Colombini, Jin Yeong Han, Erich Fradinger, M. Lavado, Francisco Ríos, Gabriel Mircescu, Helene Leray-Moragues, A. Saurina, Mahtab Baiani, Simona Stancu, Martine Leblanc, Patricia Peri, Kuan-Yu Hung, Leila Chenine, José Ignacio Merello, Marion Morena, Savino Cocola, Chih-Yen Hsiao, Carina Andrei, Simona Cinca, Adalbert Schiller, Fernando Silveira, Peir-Haur Hung, J. Macias, Manuel Canalis, José Mora, Barbara Marzell, and Berk Torun

Subjects
Transplantation, medicine.medical_specialty, Bone disease, Nephrology, business.industry, Internal medicine, medicine, medicine.disease, business
Published
2011
Full Text
View/download PDF

19. Bone disease - 2

Author

Ebru Sevinc, Cheryl Arko, J. Prado Rome, Ercan Ok, Joan Casellas, Marc Benhamou, F. Perretta, Ananda Sen, D. Verbeelen, Mary B. Leonard, Benyounes Ramdani, B. Benavides, M. Farh, Piergiorgio Messa, Svetlana Ignjatovic, Dimitrios Grekas, Paulina Dumnicka, Andreas Margioris, Vasilios Zafiropulos, Tatsuya Shoji, David Ansell, Stergios Kapoulas, Giuseppe Cannella, P.Y. Martin, Jing-fang Zhao, Vanda Jorgetti, M. Norbi, Mohamed Zamd, D. Andress, Lucila Maria Valente, F. Riad, Robert Rakowski, Hiroaki Ogata, Erika Aguilar, F.J. Ariza, Lenicio Andrade Filho, Fumihiko Koiwa, Fabiana G. Graciolli, Nathan W. Levin, Władysław Sułowicz, Feyza Sen, Susan C. Schiavi, R.L. Pisoni, Juergen Floege, Eugene Daphnis, C. Sagliker, W. Kleophas, M. Ferrero, Aureli Machado, D.S. Fuller, A. Citarelli, Takuya Uehata, Akihiro Shimomura, Jochen G. Raimann, H. Ben Maiz, R. Wilberg, Ekaterini Michalaki, M. Esenturk, S.H. Jacobson, Eriko Kinugasa, Hua Zhou, Alaa Sabry, A. Lafalla, Maria Luisa Muci, M. El Khasmi, Sonya Steppan, Katia R. Neves, A. Aralde, S. Fishbane, Renato C. Monteiro, Bruce M. Robinson, E.W. Young, G. Gomez, Andrea O. Magalhães, Aphrodite Avdelidou, Jose Maria Cruzado, Tadao Akizawa, Yoko Nishikawa, Tamara Jemcov, Analuzia Medeiros, David Goldsmith, Svetlana Pejanovic, David Fuster, Monika Krasnicka, Christopher T. Chan, Jelena Marinkovic, Marie-Claude Monier-Faugere, Shigeru Nakai, Liliana Gonzalez, Takayuki Hamano, W. Douthat, Siddik Momin Adam, Franco Citterio, Geoffrey Block, Antonio R. Gargiulo, D. Grbavac, Selda Sarikaya, Rosa M.A. Moysés, R. Cutrona, Joanne M. Bargman, Benjamín Gómez, Mario Cozzolino, Sherry Liu, Madiha Ez-Zahidy, Y. Maccio, Adrian Covic, Tetsuya Kaneko, J M Campistol, Mümtaz Yilmaz, F. De Rosa, Visnja Lezaic, Kimberly Nieman, O. Demirhan, J.V. Torregrosa, J. Bommer, O. Golea, F.D. Tentori, Elizabeth Shane, David M.J. Naimark, Ivan Gamez, John L. Griffith, L. Zarate, Takuma Hazama, Marzia Pasquali, Peter Kotanko, Srinivas Hariachar, Verônica Gouveia, Marijana Dajak, Thomas L. Nickolas, Miguel Medina, F. Gotch, Areti Hitoglou-Makedou, M. Pudu, Lidija Orlić, N. Paylar, Adriana Penalba, Assia Lahboub, C. Hsu Chen, David Zaun, X. Edward Guo, Takuo Kusumoto, W.J. Bos, Takashi Shigematsu, M. Lludgard, V. Altobelli, Dakshina Jayasena, Hartmut H. Malluche, J. Ziella, Sandra Neiva Coelho, Eyup Kulah, Marek Kuzniewski, G. Rosa Diez, Manasi Desai, Irene Katsipi, Duygu Yoruk, P.S. Ozkaynak, Mehmet Ozkahya, James Onwubalili, K. Eyupoglu, Steven Fishbane, Noriyuki Okada, J. Nagy, Fabiola Martin del Campo, H. Moretto, Fatih Kircelli, Gulay Asci, Peter J. Dupont, Martin Wagner, Kali Makedou, J.L. Fernandez-Martin, Anastasia Markaki, José Edevanilson de Barros Gueiros, Navdeep Tangri, Sylvie Schwarzova, F. Chavez, D. Pavlovic, Rolina Natso, Thomas Oates, Jose-Vicente Torregrosa, Chiaki Kumata-Maeta, Sandro Mazzaferro, G. Ibanez, F. Tornero, Irene Dermitzaki, Marisa Battistella, A. Hansen, C. Mascheroni, Geoff A. Block, A. Marcozzi, Carolina Batis, A. Kruse, Robert M. Richardson, Pavlos Mallindretos, Giusy Mandanici, Seiya Okuda, R. Kramar, Dimitrios Memmos, Bin Sun, Fumiko Kondo, Ana Paula Santana Gueiros, V. Bhalani, Athanasios Sioulis, Y. Sagliker, G. Aguirre, Francesco Pugliese, Patrik Letocha, Raffaella Lavini, Daniella G. Batista, Mohamed Gharbi Benghanem, Osamu Tamai, Jorge B. Cannata-Andía, Jana Smrzova, Marie Marsova, M. Ketteler, Diego Brancaccio, M. Sipahioglu, Yusuke Sakaguchi, Vidosava Nesic, Giuliana Pirrò, J. Bover, Sharon M. Moe, M. Molina, Jiannong Liu, Naoufal Mtioui, Beata Kusnierz-Cabala, L. Garneata, S. Setti, Huseyin Toz, R. Pérez García, R.P. Wüthrich, Jeremy Heaton, I. Yildiz, Nurcan Kara, J.L. Gorriz, Elisavet Pouliou, Changying Xing, Hiromi Irishio, C. Najun, Luciene M. dos Reis, A. Ferreira, Franco Locatelli, Zeljka Crncevic, Stephan Thijssen, H. Lopez, Takashi Akiba, P. Audhya, Ahmet Dursun, E.H. Tahri, V. Acharya, Kostas Stylianou, L. Urtiaga, Wadi N. Suki, Alexandra Hodsman, Mehmet Cabuk, Gérard M. London, Kostas Perakis, L. Leon, I. Emir, Vladimír Teplan, Melani Ribeiro Custódio, Wendy L. St. Peter, Gloria Martin, R. Giachi, Danuta Fedak, Jutta Passlick-Deetjen, Yoshiharu Tsubakihara, Milan Radovic, D. Redulescu, M. Benedik, C. Mengarelli, D. Ookalkar, Stuart M. Sprague, Masahide Mizobuchi, A. Alles, B. Rutkowski, James A. Delmez, A. Lara, N. El Abbadi, E. Hernandez, C. Scifo, Tomáš Urbánek, H. Sagliker, Carmina Conte, L. Zhang, Milous Vyskocil, C. Tielemans, Alfonso M. Cueto-Manzano, E. Dhole, Masahisa Fujisawa, J.L. Miguel Alonso, Rita Martim, and E. Del Valle

Subjects
03 medical and health sciences, Transplantation, Pathology, medicine.medical_specialty, 0302 clinical medicine, Bone disease, Nephrology, business.industry, 030232 urology & nephrology, medicine, medicine.disease, business
Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results